Published in Healthcare Finance, Tax and Law Weekly, June 6th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at PTC Therapeutics, Inc.
Report 1: PTC Therapeutics, Inc., announced that it has withdrawn its S-1 registration statement, previously filed with the Securities and Exchange Commission (SEC).
"Since we originally filed our S-1 last year, PTC has enjoyed significant business development successes which have put us in a strong financial position," said Stuart W. Peltz, Ph.D., President and Chief Executive Officer of PTC Therapeutics. "Given that we have sufficient...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.